Antibiotic resistance patterns in nosocomial gram-negative bacterial infections in units with heavy antibiotic usage

Journal of Tropical Pediatrics

Volumn 50, Issue 1, 2004, Pages 26-31

  Ariffin, Hany ^a   Navaratnam, Parasakthi ^a   Kee, Tan Kah ^b   Balan, Ganeswarie ^b  

^a UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

^b HOSPITAL SULTANAH AMINAH   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULPERAZON; TIMENTIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; DRUG EFFICACY; EMPIRICISM; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HOSPITAL ADMISSION; HOSPITAL DEPARTMENT; HOSPITAL INFECTION; HUMAN; KLEBSIELLA; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NEWBORN; NEWBORN INTENSIVE CARE; NONHUMAN; ONCOLOGY; PROSPECTIVE STUDY; PSEUDOMONAS;

ACINETOBACTER; BETA-LACTAMASES; CHILD; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITAL UNITS; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS; KLEBSIELLA; MALAYSIA; PSEUDOMONAS AERUGINOSA;

EID: 1242298598     PISSN: 01426338     EISSN: None     Source Type: Journal    
DOI: 10.1093/tropej/50.1.26     Document Type: Article

References (19)

1. Goldmann DA, Weinstein RA, Wenzel RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant micro-organisms in hospitals. JAMA 1996; 275: 234-40.
2. Shales DM, Gerding DN, John JF Jr, et al. Society for Health-care Epidemiology of America and Infectious Disease Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 1997; 25: 584--99.
3. Flaherty JP, Weinstein RA. Nosocomial infection caused by antibiotic-resistant organisms in the intensive care unit. Infect Control Hosp Epidemiol 1996; 17: 236-48.
4. Brown DFJ, Brown L. Evaluation of the E-test: a novel method of quantifying antimicrobial activity. J Antimicrob Chemother 1991; 27: 185-90.
5. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd edn. Approved standard M-7A3. NCCLS, Villanova, PA, 1993.
6. Cheong YM, Lim VKE, Jegathesan M, Suleiman AB. Antimicrobial resistance in six Malaysian general hospitals. Med J Malaysia 1994; 49: 317-26.
7. Ariffin H, Arasu A, Mahfuzah M, et al. Single-daily ceftriaxone plus amikacin vs thrice-daily ceftazidime plus amikacin as empirical therapy for children with febrile neutropenia. J Paed Child Health 2001; 37: 38-43.
8. Parasakthi N, Vadivelu J, Ariffin H, et al. Epidemiology and molecular characterization of nosocomially transmitted multi-drug resistant Klebsiella pneumoniae. Int J Infect Dis 2000; 4: 123-8.
9. Shales DM, Gerding DN, John JF, et al. Guidelines for the prevention of antimicrobial resistance in hospitals : joint statement by the Society for Health Care Epidemiology of America and the Infectious Diseases Society of America. Infect Control Hosp Epidemiol 1997; 18: 275-91.
10. McGowan JE, Gerding D. Does antibiotic restriction prevent resistance? New Horiz 1996; 4: 370-76.
11. Rahal JJ, Urban C, Segal-Maurer S. Nosocomial antibiotic resistance in multiple gram-negative species: experience at one hospital with squeezing the resistance balloon at multiple sites. Clin Infect Dis 2002; 34: 499-503.
12. Meyer KS, Urban C, Eagan JA, Berger BJ, Rahal JJ. Nosocomial outbreak of Klebsiella infection resistant to the late-generation cephalosporins. Ann Intern Med 1993; 119: 353-58.
13. Gruson D, Hilbert G, Vargas F, et al. Rotation and restricted use of antibiotics in a medical intensive care unit. Am J Respir Crit Care Med 2000; 162: 837-43.
14. Luna CM, Vujarich P, Niederman MS, et al. Impact of bronchoalveolar lavage data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997; 111: 676-85.
15. Alvarez-Lerma F. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. Intensive Care Med 1996: 22: 387-94.
16. Namias N, Harvill S, Ball S, et al. Empiric therapy of sepsis in the surgical intensive care unit with broad-spectrum antibiotics for 72 hours does not lead to the emergence of resistant bacteria. J Trauma Infec Crit Care 1998; 45: 887-91.
17. Harris A, Torres-Viera C, Venkataraman L, DeGirolami P, Samore M, Carmeli Y. Epidemiology and clinical outcomes of patients with multi-resistant Pseudomonas aeruginosa. Clin Infect Dis 1999; 28: 1128-33.
18. Miranda G, Leanos B, Marquez L, et al. Molecular epidemiology of a multi-resistant Pseudomonas aeruginosa outbreak in a paediatric intensive care unit. Scand J Infect Dis 2001; 33: 738-43.
19. Toltzis P, Dul MJ, Hoyen C, et al. Molecular epidemiology of antibiotic-resistant Gram-negative bacteria in a neonatal intensive care unit during a non-outbreak period. Pediatrics 2001; 108: 1143-48.